Medical application of ribosomal protein SA antibody in immunoregulation
The invention discloses a medical application of a ribosomal protein SA antibody in immunoregulation, and discloses a new medical application of the ribosomal protein SA antibody. According to the important role of RPSA in pathogen adhesion and invasion of host cells, the RPSA is used as a target point for immunoregulation, and immune response of organisms and cells is regulated and controlled. According to the invention, the RPSA antibody can effectively prevent the combination of pathogens and the RPSA, reduce the stimulation and damage of some pathogens to cells, and inhibit the immune response of cells to pathogens; for some pathogens with weaker immune stimulation, the antibody can properly enhance immune response to realize the regulation effect on the immune response; the antibody avoids aggravation of occurrence and development of diseases caused by excessive immune stimulation to some pathogens due to frequent pathogen infection..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 09. Juni Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LEI LIANCHENG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-06-09, Last update posted on www.tib.eu: 2022-04-09, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN111249457 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004556429 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004556429 | ||
| 003 | DE-627 | ||
| 005 | 20230504120522.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA004556429 | ||
| 035 | |a (EPA)CN111249457 | ||
| 035 | |a (EPA)70942328 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LEI LIANCHENG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medical application of ribosomal protein SA antibody in immunoregulation |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-06-09, Last update posted on www.tib.eu: 2022-04-09, Last updated: 2023-02-09 | ||
| 520 | |a The invention discloses a medical application of a ribosomal protein SA antibody in immunoregulation, and discloses a new medical application of the ribosomal protein SA antibody. According to the important role of RPSA in pathogen adhesion and invasion of host cells, the RPSA is used as a target point for immunoregulation, and immune response of organisms and cells is regulated and controlled. According to the invention, the RPSA antibody can effectively prevent the combination of pathogens and the RPSA, reduce the stimulation and damage of some pathogens to cells, and inhibit the immune response of cells to pathogens; for some pathogens with weaker immune stimulation, the antibody can properly enhance immune response to realize the regulation effect on the immune response; the antibody avoids aggravation of occurrence and development of diseases caused by excessive immune stimulation to some pathogens due to frequent pathogen infection. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHU RINING |4 aut | |
| 700 | 0 | |a LEI SIYU |4 aut | |
| 700 | 0 | |a WU TONG |4 aut | |
| 700 | 0 | |a JIANG HEXIANG |4 aut | |
| 700 | 0 | |a ZHANG XIAOGUANG |4 aut | |
| 700 | 0 | |a LIU HONGTAO |4 aut | |
| 700 | 0 | |a LI ZIHENG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 09. Juni |
| 773 | 1 | 8 | |g year:2020 |g day:09 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/70942328/publication/CN111249457A1?q=CN111249457 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 09 |c 06 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 09 |c 06 | ||